|Articles|November 15, 2001
- BioPharm International-11-01-2001
- Volume 14
- Issue 11
Liposomes (a Review), Part One: Manufacturing Issues
by Suggy S. Chrai, R. Murari, and Imran Ahmad Liposomal formulations are increasingly being used in biopharmaceutical development projects. Good manufacturing processes must reproducibly fabricate lipid vesicles that are as uniform in size as possible, carry the drug in sufficient concentration, and remain stable for an acceptable shelf-life under varying temperatures.
Advertisement
Articles in this issue
about 24 years ago
Business Matters: Eclipsed by Catastropheabout 24 years ago
Designs for Bioassays with Plate Location Effectsabout 24 years ago
Simplifying Pharmacologic Analysis with Programmable Scientific Softwareabout 24 years ago
Outsourcing Outlook: Truth in OutsourcingNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
FDA-Approved WAS Gene Therapy Hits Market in Nonprofit Model
2
Developing Next-Gen Cell Lines Using Targeted Integration
3
EU Clears Subcutaneous Biologic for Lupus, Advancing Patient-Controlled Delivery
4
Two-Minute Mysteries: BioPharm Stories - Episode 2: The Costly Myth of Noninvasive Glucose Monitoring
5
